Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Baricitinib successfully treated severe hair loss.

Ritlecitinib is effective for treating alopecia areata, showing significant hair regrowth with mild side effects.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Apremilast may help treat hair loss in alopecia areata.

A new mouse model helps understand and find treatments for alopecia areata.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Targeting specific T cells may help treat alopecia areata.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

BTNL2 helps protect hair follicles from immune attacks.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

The Fas/FasL pathway may play a role in alopecia areata.

IL-27 can prevent hair loss in alopecia areata.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Mitochondrial stress can lead to atopic dermatitis.